What is the Role of Hematopoietic Cell Transplantation (HCT) for Pediatric Acute Lymphoblastic Leukemia (ALL) in the Age of Chimeric Antigen Receptor T-Cell (CART) Therapy?
Agne Taraseviciute(Seattle Children's Hospital), Michael J. Burke(Children's Hospital of Wisconsin), Neel S. Bhatt(The Ohio State University Wexner Medical Center), Kerri Becktell(Medical College of Wisconsin), Larisa Broglie(Morgan Stanley Children's Hospital), Rachel Phelan(Children's Hospital of Wisconsin)
Cited by 22
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group
|Blood|2017|305
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy
|Blood|2019|287
In-Orbit Performance of the GRACE Follow-on Laser Ranging Interferometer
|Physical Review Letters|2019|277
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
|Nature Reviews Clinical Oncology|2018|237